Cargando…

Preclinical Models for Neuroblastoma: Establishing a Baseline for Treatment

BACKGROUND: Preclinical models of pediatric cancers are essential for testing new chemotherapeutic combinations for clinical trials. The most widely used genetic model for preclinical testing of neuroblastoma is the TH-MYCN mouse. This neuroblastoma-prone mouse recapitulates many of the features of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teitz, Tal, Stanke, Jennifer J., Federico, Sara, Bradley, Cori L., Brennan, Rachel, Zhang, Jiakun, Johnson, Melissa D., Sedlacik, Jan, Inoue, Madoka, Zhang, Ziwei M., Frase, Sharon, Rehg, Jerold E., Hillenbrand, Claudia M., Finkelstein, David, Calabrese, Christopher, Dyer, Michael A., Lahti, Jill M.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084749/ https://www.ncbi.nlm.nih.gov/pubmed/21559450 http://dx.doi.org/10.1371/journal.pone.0019133

Ejemplares similares

Large 1p36 Deletions Affecting Arid1a Locus Facilitate Mycn-Driven Oncogenesis in Neuroblastoma
por: García-López, Jesus, et al.
Publicado: (2020)

Development and characterization of a human orthotopic neuroblastoma xenograft
por: Stewart, Elizabeth, et al.
Publicado: (2015)

MYCN induces neuroblastoma in primary neural crest cells
por: Olsen, R R, et al.
Publicado: (2017)

Developing preclinical models of neuroblastoma: driving therapeutic testing
por: Ornell, Kimberly J., et al.
Publicado: (2019)

Patient-derived xenografts as preclinical neuroblastoma models
por: Braekeveldt, Noémie, et al.
Publicado: (2017)

Preclinical Models of Neuroblastoma—Current Status and Perspectives
por: Krawczyk, Ewa, et al.
Publicado: (2023)

Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Neuroblastoma
por: Gillory, Lauren A., et al.
Publicado: (2013)

Pantothenate Kinase 1 Is Required to Support the Metabolic Transition from the Fed to the Fasted State
por: Leonardi, Roberta, et al.
Publicado: (2010)

Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
por: Tucker, Elizabeth R., et al.
Publicado: (2023)

Genetic context of oncogenic drivers dictates vascular sarcoma development in aP2‐Cre mice
por: Hanna, Jason A, et al.
Publicado: (2022)

Prox1-Heterozygosis Sensitizes the Pancreas to Oncogenic Kras-Induced Neoplastic Transformation()()
por: Drosos, Yiannis, et al.
Publicado: (2016)

Germline Deletion of Pantothenate Kinases 1 and 2 Reveals the Key Roles for CoA in Postnatal Metabolism
por: Garcia, Matthew, et al.
Publicado: (2012)

Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma
por: Sun, Ming, et al.
Publicado: (2023)

Preclinical testing of chimeric antigen receptor T cells in neuroblastoma mouse models
por: Li, Nan, et al.
Publicado: (2021)

Baseline White Matter Is Associated With Physical Fitness Change in Preclinical Alzheimer’s Disease
por: Venkatraman, Vijay K., et al.
Publicado: (2020)

Preclinical evaluation of the anti-tumor activity of pralatrexate in high-risk neuroblastoma cells
por: Clark, Rachael A., et al.
Publicado: (2020)

IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma models
por: Stip, Marjolein C, et al.
Publicado: (2023)

The Potential of Avian H1N1 Influenza A Viruses to Replicate and Cause Disease in Mammalian Models
por: Koçer, Zeynep A., et al.
Publicado: (2012)

Is statistical re-evaluation of hemolymphoreticular neoplasms from aspartame studies valid?
por: Elmore, Susan A, et al.
Publicado: (2023)

The EMIF-AD PreclinAD study: study design and baseline cohort overview
por: Konijnenberg, Elles, et al.
Publicado: (2018)

Preclinical Development of [(211)At]meta- astatobenzylguanidine ([(211)At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma
por: Batra, Vandana, et al.
Publicado: (2022)

A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies
por: Althoff, K, et al.
Publicado: (2015)

Effect of Neuraminidase Inhibitor–Resistant Mutations on Pathogenicity of Clade 2.2 A/Turkey/15/06 (H5N1) Influenza Virus in Ferrets
por: Ilyushina, Natalia A., et al.
Publicado: (2010)

Evaluation of the DLL3-targeting Antibody–Drug Conjugate Rovalpituzumab Tesirine in Preclinical Models of Neuroblastoma
por: Krytska, Kateryna, et al.
Publicado: (2022)

The Promise of Patient-Derived Preclinical Models to Accelerate the Implementation of Personalised Medicine for Children with Neuroblastoma
por: Tucker, Elizabeth R., et al.
Publicado: (2021)

ERK1/2 Inhibition Alleviates Noise-Induced Hearing Loss While Tempering Down the Immune Response
por: Lutze, Richard D., et al.
Publicado: (2023)

Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastoma
por: Chen, Lindi, et al.
Publicado: (2019)

Adrenal neuroblastoma in an elderly adult: a case report and review of the literature
por: Zhang, Haibin, et al.
Publicado: (2019)

Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy
por: Kamili, Alvin, et al.
Publicado: (2020)

The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models
por: Pajtler, Kristian W, et al.
Publicado: (2016)

Induction of Neuron-Specific Degradation of Coenzyme A Models Pantothenate Kinase-Associated Neurodegeneration by Reducing Motor Coordination in Mice
por: Shumar, Stephanie A., et al.
Publicado: (2015)

Pharmacokinetics and Efficacy of the Spleen Tyrosine Kinase Inhibitor R406 after Ocular Delivery for Retinoblastoma
por: Pritchard, Eleanor M., et al.
Publicado: (2014)

How Do Own and Siblings’ Genders Shape Caregivers’ Risk of Perceiving Care-Related Criticism From Siblings?
por: Rurka, Marissa M, et al.
Publicado: (2022)

DNA Ligase III is critical for mtDNA integrity but not Xrcc1-mediated nuclear DNA repair
por: Gao, Yankun, et al.
Publicado: (2011)

Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma
por: Moghimi, Babak, et al.
Publicado: (2021)

Use of Preclinical Models to Improve Treatment of Retinoblastoma
por: Dyer, Michael A, et al.
Publicado: (2005)

Does Pandemic A/H1N1 Virus Have the Potential To Become More Pathogenic?
por: Ilyushina, Natalia A., et al.
Publicado: (2010)

Characteristics of Treatment Seeking Finnish Pathological Gamblers: Baseline Data from a Treatment Study
por: Lahti, Tuuli, et al.
Publicado: (2012)

Preclinical In Vitro Studies with 3D Spheroids to Evaluate Cu(DDC)(2) Containing Liposomes for the Treatment of Neuroblastoma
por: Hartwig, Friederike, et al.
Publicado: (2021)

Detection and therapy of neuroblastoma minimal residual disease using [(64/67)Cu]Cu-SARTATE in a preclinical model of hepatic metastases
por: Dearling, Jason L. J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8k21u9o2s0vc7i731i6s6ou5dk